Martin Dekker
Overview
Martin Dekker received $412K in total compensation, including $190K in salary, at Bellerophon Therapeutics in 2015.
Source: SEC filing on April 27, 2016.
Related executives
We found seven more executives who work or worked at Bellerophon Therapeutics.
Fabian Tenenbaum
Bellerophon Therapeutics
Chief Executive Officer
Peter Fernandes
Bellerophon Therapeutics
Chief Regulatory and Safety Officer
Assaf Korner
Bellerophon Therapeutics
Chief Financial Officer
Deborah Quinn
Bellerophon Therapeutics
Chief Medical Officer
Jonathan Peacock
Bellerophon Therapeutics
Chief Executive Officer
Martin Meglasson
Bellerophon Therapeutics
Chief Scientific Officer
Reinilde Heyrman
Bellerophon Therapeutics